BioSpace News Archive

Leading PT provider in the Northeast grows outpatient offerings through on-demand, delivery PT service

Award from The Joint Commission, Kaiser Permanente, honors Bernard J. Tyson, late chief executive officer and reform advocate

The International Society for Magnetic Resonance in Medicine is holding its Annual Meeting this week and will recognize several achievements with prestigious awards.

Life-saving initiative will provide pharmaceutical-grade medication as alternative to toxic illegal drug supply during COVID-19 pandemic and beyond

Advicenne (Euronext: ADVIC), a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those suffering from rare renal diseases, announces US Food and Drug Administration (FDA) acceptance of the amended protocol of the Company’s US-based Phase III pivotal trial of ADV7103 (Sibnayal™) for the treatment of primary distal renal tubular acidosis (dRTA).

Novo Nordisk today presented results from RESCUE, a phase 2 randomised, double-blind, placebo controlled clinical trial assessing the effect of once-monthly, investigational ziltivekimab, an interleukin-6 (IL-6) inhibitor, on biomarkers of inflammation.

adMare BioInnovations (“adMare”) and AazeinTx Inc. (“AazeinTx”) have closed a global exclusive licensing transaction for a promising acute asthma treatment.

Lumen , a health tech company and the creators of the world’s first portable metabolism measurement device, has officially been peer-reviewed and published in the Interactive Journal of Medical Research (I-JMR).

The Medical Device Innovation Consortium announced a partnership with Booz Allen Hamilton to establish a benchmark of the medical device industry’s cybersecurity maturity and create resources to measure maturity over time.

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.